What is it about?
This article contains the perspectives of a kidney transplant recipient regarding the potential benefits of more molecular testing of kidney transplant biopsies. It proposes that more studies be conducted to support the findings of a study that proposes that molecular testing of kidney transplant biopsies may find more instances of kidney transplant rejection than standard practices currently do.
Featured Image
Read the Original
This page is a summary of: Biopsy-Based Transcriptomics May Be Precisely What Is Needed in Post-Kidney Transplant Care, Clinical Journal of the American Society of Nephrology, August 2024, Wolters Kluwer Health,
DOI: 10.2215/cjn.0000000000000539.
You can read the full text:
Contributors
The following have contributed to this page







